Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is well-positioned for long-term growth due to its unique and comprehensive hybrid model including in-person and virtual care, deep clinical capabilities, and focus on outcomes. With high demand and impressive productivity metrics, the company's disciplined growth and margin strategy is expected to result in improved earnings and revenue growth in the future. However, competition in the mental health space and potential impacts from economic fluctuations or cybersecurity could present risks for the company. Overall, the outlook for LifeStance Health Gr remains positive given the increasing prevalence of mental illness and the demand for high-quality mental healthcare services.

Bears say

LifeStance Health Gr is one of the largest mental health platforms serving both in-person and virtual care. While they have a unique differentiator, their increasing competition in the market, potential impacts from economic downturns, and challenges with data and security could negatively impact their market share and reputation. While they have seen strong growth and improved operations, their valuation of EV/13.2x 2027E EBITDA is higher than the subsector average, which could present some risks for investors.

LFST has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 8 analysts, LFST has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.